Patients with epilepsy who experience frequent seizures and have a long duration of illness before control are more likely to have higher recurrence rates and poorer prognosis. Early treatment leads to better efficacy and improved prognosis. Patients whose seizures are quickly controlled with a single medication at standard doses generally have a better prognosis. Most patients who enter remission do so within the first two years of onset, and the likelihood of achieving remission decreases over time. Different individuals may respond better to one specific antiepileptic drug, and many patients who achieve long-term remission demonstrate that epilepsy can have a self-limiting course. Epilepsy patients who experience status epilepticus have a better prognosis compared to those who develop status epilepticus due to other conditions, as they can receive timely diagnosis or treatment with antiepileptic drugs.